James Edgemond's Net Worth
$12.1 Million
Who is James Edgemond?
James Edgemond has an estimated net worth of $12.1 Million. This is based on reported shares in UNITED THERAPEUTICS Corp.
SEC CIK
James Edgemond's CIK is 0001636178
Past Insider Trading and Trends
2024 was James Edgemond's most active year for acquiring shares with 14 total transactions. James Edgemond's most active month to acquire stocks was the month of February. 2024 was James Edgemond's most active year for disposing of shares, totalling 28 transactions. James Edgemond's most active month to dispose stocks was the month of July. 2024 saw James Edgemond paying a total of $9,532,271.96 for 65,156 shares, this is the most they've acquired in one year. In 2024 James Edgemond cashed out on 128,728 shares for a total of $19,058,781.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
UNITED THERAPEUTICS Corp (UTHR) Snapshot price: $345.63
CFO AND TREASURER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.40% | 556 |
$246.51 | -$1,917,505.72 | 8.07K |
Scheduled
|
Nov 4
| ||
Form 4
| +7.65% | 534 |
$234.50 | -$1,738,378.16 | 7.51K |
Scheduled
|
Oct 28
| ||
Form 4
| +8.59% | 552 |
$242.99 | -$1,864,294.34 | 6.98K |
Scheduled
|
Oct 21
| ||
Form 4
| +9.21% | 542 |
$249.67 | -$1,577,395.12 | 6.43K |
Scheduled
|
Oct 14
| ||
Form 4
| +14.01% | 524 |
$229.06 | -$1,656,905.36 | 4.26K |
Scheduled
|
Sep 16
| ||
Form 4
| +16.51% | 530 |
$232.20 | -$1,703,507.50 | 3.74K |
Scheduled
|
Sep 9
| ||
Form 4
| +20.92% | 547 |
$240.68 | -$1,829,669.13 | 3.16K |
Scheduled
|
Sep 3
| ||
Form 4
| +25.60% | 533 |
$233.29 | -$1,719,551.08 | 2.62K |
Scheduled
|
Aug 26
| ||
Form 4
| +31.94% | 504 |
$224.00 | -$1,584,187.24 | 2.08K |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$218.00 | -$4,393,102.40 | 1.58K |
May 15
| |||
Form 4
|
—
|
0
|
$166.43 | -$1,487,706.24 | 1.38K |
Nov 7
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |